Traumatic Brain Injury (TBI) Treatment Adv Tech
Abstract
This Project covers development, demonstration, and transition of technologies for acute battlefield management of brain trauma. Efforts include pre-clinical demonstration of drug therapy and resuscitation strategies for treatment of acute brain injury in the pre-hospital setting, biomarkers, diagnostics, and devices, as well as novel drug delivery technologies to facilitate administration of pharmaceuticals at or near the point of injury to protect the injured brain from further damage. All research is conducted in compliance with Food and Drug Administration (FDA) requirements for licensure of medical products for human use. Promising efforts identified through Applied Research conducted under PE 0602787A (Medical Technology) Project MM4 (Cbt Casualty Care Applied Rsch Technology) are further matured under this Project. Promising results identified under this Project are further matured under PE 0603807A (Medical Systems Advanced Development) Project 836 (Field Medical Systems Advanced Development). The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. Work in this Project is performed by the United States Army Medical Research Development Command (USAMRDC), Fort Detrick, MD.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2021
- Source ID
- MO2_0603002A_3_2040_PB_2021
Related Documents
- Root: Medical Advanced Technology
- Child Accomplishment: Drugs to Prevent and Treat Brain Injury (TBI)
- Child Accomplishment: FY 2020 SBIR/STTR Transfer